Renaissance Capital Partners Ltd - Net Worth and Insider Trading

Renaissance Capital Partners Ltd Net Worth

The estimated net worth of Renaissance Capital Partners Ltd is at least $7,389 dollars as of 2024-06-10. Renaissance Capital Partners Ltd is the 10% Owner of TC BioPharm (Holdings) PLC and owns about 6,842 shares of TC BioPharm (Holdings) PLC (TCBP) stock worth over $7,389. Details can be seen in Renaissance Capital Partners Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Renaissance Capital Partners Ltd has not made any transactions after 2022-11-30 and currently still holds the listed stock(s).

Transaction Summary of Renaissance Capital Partners Ltd

Renaissance Capital Partners Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Renaissance Capital Partners Ltd owns 1 companies in total, including TC BioPharm (Holdings) PLC (TCBP) .

Click here to see the complete history of Renaissance Capital Partners Ltd’s form 4 insider trades.

Insider Ownership Summary of Renaissance Capital Partners Ltd

Ticker	Comapny	Transaction Date	Type of Owner
TCBP	TC BioPharm (Holdings) PLC	2022-11-30	10 percent owner

Renaissance Capital Partners Ltd Latest Holdings Summary

Renaissance Capital Partners Ltd currently owns a total of 1 stock. Renaissance Capital Partners Ltd owns 6,842 shares of TC BioPharm (Holdings) PLC (TCBP) as of November 30, 2022, with a value of $7,389.

Latest Holdings of Renaissance Capital Partners Ltd

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TCBP	TC BioPharm (Holdings) PLC	2022-11-30	6,842	1.08	7,389

Holding Weightings of Renaissance Capital Partners Ltd

Renaissance Capital Partners Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Renaissance Capital Partners Ltd has made a total of 1 transactions in TC BioPharm (Holdings) PLC (TCBP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TC BioPharm (Holdings) PLC is the acquisition of 3,500 shares on November 30, 2022, which cost Renaissance Capital Partners Ltd around $350,000.

Insider Trading History of Renaissance Capital Partners Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Renaissance Capital Partners Ltd Trading Performance

GuruFocus tracks the stock performance after each of Renaissance Capital Partners Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renaissance Capital Partners Ltd is -14.44%. GuruFocus also compares Renaissance Capital Partners Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renaissance Capital Partners Ltd within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Renaissance Capital Partners Ltd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Renaissance Capital Partners Ltd

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-18.26
Relative Return to S&P 500(%)	-12.36

Renaissance Capital Partners Ltd Ownership Network

Ownership Network List of Renaissance Capital Partners Ltd

No Data

Ownership Network Relation of Renaissance Capital Partners Ltd

Renaissance Capital Partners Ltd Owned Company Details

What does TC BioPharm (Holdings) PLC do?

Who are the key executives at TC BioPharm (Holdings) PLC?

Renaissance Capital Partners Ltd is the 10 percent owner of TC BioPharm (Holdings) PLC. Other key executives at TC BioPharm (Holdings) PLC include 10 percent owner Diana Elizabeth Randall , 10 percent owner Kenneth Edward Randall , and 10 percent owner Mark Edward Randall .

TC BioPharm (Holdings) PLC (TCBP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TC BioPharm (Holdings) PLC (TCBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TC BioPharm (Holdings) PLC (TCBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TC BioPharm (Holdings) PLC (TCBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

TC BioPharm (Holdings) PLC Insider Transactions

No Available Data

Renaissance Capital Partners Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Renaissance Capital Partners Ltd. You might contact Renaissance Capital Partners Ltd via mailing address: 42 Shad Thames, London X0 Se1 2yd.

Discussions on Renaissance Capital Partners Ltd

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.